Skip to main content
OpenTrials
Completed

NCT Number: NCT05970874

Evaluation of Hand Grip Strength in Pregnant COVID-19 Patients

It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral Pregnancy Related RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

Female

Study type

Observational

Primary location

Hatice Toprak

Karaman, Merkez, 70200, Turkey (Türkiye)

About this study

Covid 19 is the disease defined for strains infected with severe acute respiratory syndrome coronavirus 2(Sars-CoV-2). Hand grip strength is a non-invasive, easily applicable, objective parameter. It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19

Exclusion criteria

  • Those with orthopedic defects in the dominant hand and wrist and those with hand, wrist and shoulder involvement on the side of the measurement related to rheumatological diseases were excluded from the study.

Treatment and study plan

Hand grip strength measureme

Device

Hand grip strength (HSG) was measured in kg with the CAMRY Digital Hand Dynamometer (Model No. EH101, CAMRY).

Primary outcomes

  1. Hand grip strength assessment

    Time frame: The first 24 hours after admission to the service.

    Hand grip strength assessment in pregnancy Covid 19.

Secondary outcomes

  1. symptoms

    Time frame: The first 24 hours after admission to the service.

    Common symptoms of pregnant Covid 19 patients.

  2. laboratory findings

    Time frame: The first 24 hours after admission to the service.

    Common laboratory findings of pregnant Covid 19 patients.

  3. Vaccine

    Time frame: pre-infection period was questioned

    Vaccine rate of pregnant Covid 19 patients.

  4. Smoking

    Time frame: pre-infection period was questioned

    Smoking rate of pregnant Covid 19 patients.

Sponsors and collaborators

Lead sponsor

Karaman Training and Research Hospital

Other

Registry information

Official study title

Musculoskeletal Pain in Pregnant Infected With COVID-19, Evaluation of Fatigue and Muscle Grip Strength

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Aug 1, 2023
Registry last updated
Aug 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.